ATE365558T1 - Adsorptionsmittel in oraler darreichungsform - Google Patents

Adsorptionsmittel in oraler darreichungsform

Info

Publication number
ATE365558T1
ATE365558T1 AT02007918T AT02007918T ATE365558T1 AT E365558 T1 ATE365558 T1 AT E365558T1 AT 02007918 T AT02007918 T AT 02007918T AT 02007918 T AT02007918 T AT 02007918T AT E365558 T1 ATE365558 T1 AT E365558T1
Authority
AT
Austria
Prior art keywords
units
lowered
gpt
meq
glutamic
Prior art date
Application number
AT02007918T
Other languages
German (de)
English (en)
Inventor
Naohiro Sonobe
Michihito Ise
Susumu Morimoto
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of ATE365558T1 publication Critical patent/ATE365558T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Steroid Compounds (AREA)
AT02007918T 2001-04-11 2002-04-09 Adsorptionsmittel in oraler darreichungsform ATE365558T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001112264A JP3522708B2 (ja) 2001-04-11 2001-04-11 経口投与用吸着剤
CA2433368A CA2433368C (en) 2001-04-11 2003-06-25 Adsorbent for oral administration

Publications (1)

Publication Number Publication Date
ATE365558T1 true ATE365558T1 (de) 2007-07-15

Family

ID=34227260

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02007918T ATE365558T1 (de) 2001-04-11 2002-04-09 Adsorptionsmittel in oraler darreichungsform

Country Status (8)

Country Link
US (1) US20020176840A1 (https=)
EP (1) EP1249241B9 (https=)
JP (1) JP3522708B2 (https=)
AT (1) ATE365558T1 (https=)
CA (1) CA2433368C (https=)
DE (2) DE60220849D1 (https=)
DK (1) DK1249241T3 (https=)
ES (1) ES2288176T3 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6830753B2 (en) 2001-04-11 2004-12-14 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
DK1407772T3 (da) * 2002-10-09 2006-12-11 Kureha Corp Farmaceutisk præparat, der omfatter poröst sfærisk carbonholdigt stof, og dets anvendelse til behandling af nyre- og leversygdomme
US7651974B2 (en) 2002-11-01 2010-01-26 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
KR100680448B1 (ko) * 2002-11-01 2007-02-08 가부시키가이샤 쿠레하 경구투여용 흡착제, 신질환 치료 또는 예방제 및 간질환치료 또는 예방제
KR100680449B1 (ko) * 2002-11-01 2007-02-08 가부시키가이샤 쿠레하 경구투여용 흡착제
JP3585043B2 (ja) 2003-01-22 2004-11-04 メルク・ホエイ株式会社 医薬用吸着剤及びその製法
CN1764465A (zh) * 2003-04-03 2006-04-26 吴羽化学工业株式会社 低代谢转化型骨病的治疗或预防药物
AU2003204621B8 (en) * 2003-06-11 2010-04-22 Kureha Corporation Adsorbent for oral administration
KR101135260B1 (ko) * 2003-10-22 2012-04-12 가부시키가이샤 쿠레하 경구투여용 흡착제, 신질환 치료 또는 예방제 및 간질환치료 또는 예방제
US20070231394A1 (en) * 2004-02-06 2007-10-04 Sumie Goto Agent for Removing Circulatory Dysfunction Factor
TWI385120B (zh) * 2004-04-02 2013-02-11 Kureha Corp 球狀活性碳之製造方法
TWI370012B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI370013B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
WO2005110444A1 (ja) * 2004-05-18 2005-11-24 Kureha Corporation 眼疾患の治療又は予防剤
CA2569684C (en) * 2004-06-07 2014-10-07 Kureha Corporation Dry composition for oral ingestion and gel composition prepared just before use for oral ingestion
JP4693030B2 (ja) * 2004-11-08 2011-06-01 オルガノ株式会社 活性炭の製造方法
EP1886689A4 (en) * 2005-05-16 2009-07-22 Kureha Corp INHIBITOR OF OXIDATIVE STRESS
JP2007045775A (ja) * 2005-08-11 2007-02-22 Japan Organo Co Ltd 含水活性炭及びその製造方法
US8247072B2 (en) 2006-02-14 2012-08-21 Eastman Chemical Company Resol beads, methods of making them and methods of using them
DE102008014109A1 (de) * 2008-03-13 2009-09-17 Bayer Animal Health Gmbh Suspensionsformulierung für Kohlenstoff-Adsorbentien
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
WO2010086985A1 (ja) * 2009-01-29 2010-08-05 旭有機材工業株式会社 経口投与用吸着剤
JP5376592B2 (ja) * 2009-10-15 2013-12-25 産協企業有限股▲ふん▼公司 球形活性炭及びその製造方法
JP5765649B2 (ja) 2010-03-10 2015-08-19 株式会社ダステック 吸着炭及び吸着剤
JP5984352B2 (ja) 2010-10-12 2016-09-06 フタムラ化学株式会社 経口投与用医薬用吸着剤の製造方法
CN103491949B (zh) 2011-03-04 2017-02-08 株式会社吴羽 片剂型的口服给药用组合物及其制造方法
GB201204696D0 (en) 2012-03-16 2012-05-02 Ucl Business Plc Therapy
CN105688832A (zh) * 2016-03-08 2016-06-22 东南大学 一种低成本改性烟草焦脱汞吸附剂的制备方法
JP7228498B2 (ja) 2018-10-24 2023-02-24 フタムラ化学株式会社 フェノール樹脂の製造方法
CN109135791A (zh) * 2018-10-24 2019-01-04 山西新华化工有限责任公司 工业化的沥青融并成球的制备方法
PH12021552527A1 (en) 2019-04-16 2022-08-08 Futamura Kagaku Kk Method for producing activated carbon adsorbent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565313A (en) * 1979-06-26 1981-01-20 Kureha Chem Ind Co Ltd Detoxificating spherical active carbon and preparing the same
JPS5489010A (en) * 1977-12-27 1979-07-14 Kureha Chem Ind Co Ltd Spherical activated charcoal antidote
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS62223125A (ja) * 1979-06-26 1987-10-01 Kureha Chem Ind Co Ltd 経口解毒剤
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
CA2162086A1 (en) * 1994-11-15 1996-05-16 Michihito Ise Agent for reducing nephrotoxicity due to medicine
JPH08208491A (ja) * 1994-11-15 1996-08-13 Kureha Chem Ind Co Ltd 薬剤の腎毒性軽減剤

Also Published As

Publication number Publication date
DE60220849D1 (de) 2007-08-09
EP1249241A1 (en) 2002-10-16
DE60220849T2 (de) 2007-10-25
JP2002308785A (ja) 2002-10-23
JP3522708B2 (ja) 2004-04-26
ES2288176T3 (es) 2008-01-01
DE60220849T4 (de) 2008-06-05
EP1249241B9 (en) 2008-06-25
CA2433368A1 (en) 2004-12-25
DK1249241T3 (da) 2007-10-22
US20020176840A1 (en) 2002-11-28
CA2433368C (en) 2011-07-05
EP1249241B1 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
ATE365558T1 (de) Adsorptionsmittel in oraler darreichungsform
TW200517139A (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
RU99116025A (ru) Новые водные готовые лекарственные формы для получения беспропеллентных аэрозолей
CA2504517A1 (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
SI1227806T1 (sl) Farmacevtska formulacija, ki vsebuje tolterodin in njena uporaba
RU2006118801A (ru) Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
Van de Graaff et al. Adsorbent and cathartic inhibition of enteral drug absorption.
ATE123939T1 (de) Pharmazeutische zubereitung mit verbessertem geschmack, poröse partikel enthaltend, und deren herstellungsmethode.
EP0311244B1 (en) Complex of magnesium oxide and titanium dioxide as a phosphate adsorbent
JP2002521468A5 (https=)
KR20190109452A (ko) 대기 오염 물질에의 노출 위험을 감소시키기 위한 비강 약학적 조성물
RU2005116683A (ru) Адсорбент для перорального введения
CA2306748A1 (en) Treatment of fibromyalgia and related disorders
WO2001080619A3 (en) Pharmaceutical composition containing citalopram
DE60217903D1 (de) Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
EP1323422B8 (en) Pharmaceutical composition comprising midazolam for buccal administration
ES2276516T3 (es) Metodo mejorado de erradicacion del helicobacter pylori.
DE60213819D1 (de) Pharmazeutische Zubereitung enthaltend poröse sphärische kohlenstoffhaltige Teilchen und deren Verwendung zur Behandlung von Leber- und Nierenerkrankungen
JP2006111604A5 (https=)
JP4618409B2 (ja) 経口尿毒症毒素吸着剤
JP4365533B2 (ja) アルコール中毒症の治療のためのデオキシペガニン含有医薬組成物
RU2003135201A (ru) Применение антагониста опиоидов налтрексона для предупреждения и контроля побочных воздействий, вызванных опиоидами
TW200500084A (en) Adsorbent for oral administration and pharmaceutical composition, and method of manufacturing absorbent for oral administration
NO20016255L (no) Kromeno[4,3,2-de]isoquinoline som potente dopamineresepter ligander

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1249241

Country of ref document: EP